RespireRx Pharmaceuticals Inc (RSPI)

[hondobud]

I've been in and out of Pharma for many years and learn something new frequently. Even though the CEO says phase 3 can be a long process I'm under the impression it is pretty straight forward, and results will be clearly evident relatively quickly. Later, when it comes to human trials those groups should fill quickly because of the recent restraint on opioids and the millions of patients seeking pain relief and something better than just NSADS. IMO, likely KRM-II-81 would be compounded with NSAIDS as some opioid medications are formulated today. GLTA HB